Down-regulation of heat-shock protein 27-induced resistance to photodynamic therapy in oral cancer cells

Journal of Oral Pathology and Medicine

Volumn 42, Issue 1, 2013, Pages 9-16

  Kim, Jisun ^a   Jung, Hyuncheol ^a   Lim, Wonbong ^a   Kim, Sangwoo ^a   Ko, Youngjong ^a   Karna, Sandeep ^a   Kim, Oksu ^a   Choi, Yooduk ^a   Choi, Hongran ^a   Kim, Okjoon ^a  

^a Chonnam National University   (South Korea)

Author keywords

Cell death; Heat shock protein 27 (HSP27); Photodynamic therapy (PDT)

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; HEAT SHOCK PROTEIN 27; HEMATOPORPHYRIN; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL SURVIVAL; CONFOCAL MICROSCOPY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IRRADIATION; MOUTH CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 85027949313     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01155.x     Document Type: Article

References (44)

1. Van duijnhoven FH, Aalbers RI, Rovers JP, et al. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2003; 207: 105-13.
2. Chen HM, Chen CT, Yang H, et al. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy. J Oral Pathol Med 2005; 34: 253-6.
3. Dolmans DE, Fukumura D. Jain RK Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3: 380-7.
4. Mccaughan JS Jr, Ellison EC, Guy JT, et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year studyAnn Thorac Surg 1996; 62: 1005-9, discussion 1009-10.
5. Ell CClinical photodynamic therapy: where is it heading?Endoscopy 1998; 30: 408-11.
6. Maier A, Tomaselli F, Gebhard F, et al. Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiationAnn Thorac Surg 2000; 69: 1006-9.
7. Kessel DPhotodynamic therapy and neoplastic diseaseOncol Res 1992; 4: 219-25.
8. Henderson BW, Dougherty TJHow does photodynamic therapy work?Photochem Photobiol 1992; 55: 145-57.
9. Buytaert E, Dewaele M, Agostinis PMolecular effectors of multiple cell death pathways initiated by photodynamic therapyBiochim Biophys Acta 2007; 1776: 86-107.
10. Zhao H, Xing D, Chen QNew insights of mitochondria reactive oxygen species generation and cell apoptosis induced by low dose photodynamic therapyEur J Cancer 2011; 47: 2750-61.
11. Oleinick NL, Evans HHThe photobiology of photodynamic therapy: cellular targets and mechanismsRadiat Res 1998; 150: S146-56.
12. Choi H, Lim W, Kim JE, et al. Cell death and intracellular distribution of hematoporphyrin in a KB cell linePhotomed Laser Surg 2009; 27: 453-60.
13. Chu ES, Wu RW, Yow CM, et al. The cytotoxic and genotoxic potential of 5-aminolevulinic acid on lymphocytes: a comet assay studyCancer Chemother Pharmacol 2006; 58: 408-14.
14. Calzavara-pinton PG, Venturini M, Sala RPhotodynamic therapy: update 2006 Part 1: Photochemistry and photobiologyJ Eur Acad Dermatol Venereol 2007; 21: 293-302.
15. Ibbotson SHAdverse effects of topical photodynamic therapyPhotodermatol Photoimmunol Photomed 2011; 27: 116-30.
16. Wolf P, Fink-puches R, Reimann-weber A, et al. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed siteDermatology 1997; 194: 53-4.
17. Wennberg AM, Stenquist B, Stockfleth E, et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized studyTransplantation 2008; 86: 423-9.
18. Hayami J, Okamoto H, Sugihara A, et al. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acidJ Dermatol 2007; 34: 320-7.
19. Finlan LE, Kernohan NM, Thomson G, et al. Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivoBr J Dermatol 2005; 153: 1001-10.
20. Sanovic R, Krammer B, Grumboeck S, et al. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericinInt J Oncol 2009; 35: 921-39.
21. Shen XY, Zacal N, Singh G, et al. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cellsPhotochem Photobiol 2005; 81: 306-13.
22. Wang HP, Hanlon JG, Rainbow AJ, et al. Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stressPhotochem Photobiol 2002; 76: 98-104.
23. Di domenico F, Sultana R, Tiu GF, et al. Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer diseaseBrain Res 2010; 1333: 72-81.
24. Mayhew S, Vernon DI, Schofield J, et al. Investigation of cross-resistance to a range of photosensitizers, hyperthermia and UV light in two radiation-induced fibrosarcoma cell strains resistant to photodynamic therapy in vitroPhotochem Photobiol 2001; 73: 39-46.
25. Singh G, Espiritu M, Shen XY, et al. In vitro induction of PDT resistance in HT29, HT1376 and SK-N-MC cells by various photosensitizersPhotochem Photobiol 2001; 73: 651-6.
26. Huang H, Zhao X, Chen Y, et al. Apoptosis induced by ZnPcH1-based photodynamic therapy in Jurkat cells and HEL cellsInt J Hematol 2011; 94: 539-44.
27. Gollnick SO, Owczarczak B, Maier PPhotodynamic therapy and anti-tumor immunityLasers Surg Med 2006; 38: 509-15.
28. Ferrario A, Chantrain CF, Von Tiehl K, et al. The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor modelCancer Res 2004; 64: 2328-32.
29. Kim SC, Stice JP, Chen L, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosisCirc Res 2009; 105: 1186-95.
30. Luo X, Zuo X, Zhou Y, et al. Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytesArthritis Res Ther 2008; 10: R41.
31. Djamali A, Reese S, Oberley T, et al. Heat shock protein 27 in chronic allograft nephropathy: a local stress responseTransplantation 2005; 79: 1645-57.
32. Sarto C, Valsecchi C, Magni F, et al. Expression of heat shock protein 27 in human renal cell carcinomaProteomics 2004; 4: 2252-60.
33. Gomer CJ, Ryter SW, Ferrario A, et al. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteinsCancer Res 1996; 56: 2355-60.
34. Hanlon JG, Adams K, Rainbow AJ, et al. Induction of Hsp60 by Photofrin-mediated photodynamic therapyJ Photochem Photobiol, B 2001; 64: 55-61.
35. Feng H, Zeng Y, Whitesell L, et al. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunityBlood 2001; 97: 3505-12.
36. Flohe SB, Bruggemann J, Lendemans S, et al. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotypeJ Immunol 2003; 170: 2340-8.
37. Vargas-roig LM, Fanelli MA, Lopez LA, et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samplesCancer Detect Prev 1997; 21: 441-51.
38. Rui Z, Jian-guo J, Yuan-peng T, et al. Use of serological proteomic methods to find biomarkers associated with breast cancerProteomics 2003; 3: 433-9.
39. Curry PM, Levy JGStress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivativePhotochem Photobiol 1993; 58: 374-9.
40. Jacquier-sarlin MR, Polla BSDual regulation of heat-shock transcription factor (HSF) activation and DNA-binding activity by H2O2: role of thioredoxinBiochem J 1996; 1: 187-93.
41. Stokoe D, Engel K, Campbell DG, et al. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteinsFEBS Lett 1992; 313: 307-13.
42. Usuda J, Chiu SM, Murphy ES, et al. Domain-dependent photodamage to Bcl-2 A membrane anchorage region is needed to form the target of phthalocyanine photosensitizationJ Biol Chem 2003; 278: 2021-9.
43. Usuda J, Azizuddin K, Chiu SM, et al. Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapyPhotochem Photobiol 2003; 78: 1-8.
44. Usuda J, Hirata T, Ichinose S, et al. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamageInt J Oncol 2008; 33: 689-96.